Genetco

Wyeth Pharmaceutical manufactures a range of products related to cardiovascular and metabolic diseases, inflammation, biotherapeutics and musculoskeletal biology. It offers research and development programs that are focused on small molecules, vaccines and biotechnology. The division explores more than 90 therapies for medical conditions, such as diabetes, breast cancer, multiple sclerosis, schizophrenia and Alzheimer s disease. It also offers treatment for psychological and physiological health issues. With a location in Pearl River, N.Y., Wyeth Pharmaceutical is owned and operated by Wyeth, which provides biological and pharmaceutical products. The company additionally provides online health-related tools and resources.

Boehringer Ingelheim Pharmaceuticals is a Connecticut-based company that is one of the largest U.S.-based subsidiaries of Boehringer Ingelheim Corporation. Boehringer Ingelheim Pharmaceuticals funds research studies in the areas of urologic disease, benign prostatic hypertrophy, oncology, female sexual health, hypoactive sexual desire disorder, diabetes and general pharmacy. The holding company is one of the world s leading pharmaceutical companies. It operates more than 150 affiliates in over 45 countries worldwide, as well as manages a staff of approximately 30,000 employees. Boehringer Ingelheim Corporation, since its founding in 1885, is a family-owned company. It additionally focuses on the development, manufacturing and marketing of novel therapeutic products for human and animals.